Late Stage Pharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Protein Analytical Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
J Pharm Sci. 2021 Apr;110(4):1615-1624. doi: 10.1016/j.xphs.2020.09.052. Epub 2020 Oct 7.
Health authorities require that suitable stability of the drug substance be shown in relevant materials of construction. ICH Q1A(R2) explicitly states that "stability studies should be conducted on drug substance packaged in a container closure system that is the same as or simulates the packaging proposed for storage and distribution". Stainless steel containers are commonly used for the long-term storage of frozen bulk drug substances (DSs). Hastelloy®-based metal containers are sometimes used due to their higher corrosion resistance and significantly lower iron content to mitigate the potential corrosion-related risks associated with high salt formulations. Despite their benefits, we have found that elevated temperature stability studies in small scale Hastelloy® containers can lead to degradation that is not representative of degradation under typical storage conditions relevant to the manufacturing process. We provide evidence for an oxidation-induced aggregation mechanism that is based on Fenton chemistry with peroxide being supplied by the autoxidation of polysorbate at stress temperatures. Further, variation in the rates of iron leaching between individual small scale containers is shown to be the cause of the variable rates of degradation through strong correlations between leached iron levels and the extents of oxidation and aggregation. The addition of a metal chelator or the removal of polysorbate from the formulation mitigates the oxidation and the non-representative behavior. Extended characterization by LC-MS and O labeled peptide mapping shows that a significant portion of the aggregate formed under these conditions is covalently crosslinked and that the predominant covalent species is either a dityrosine or tyrosine-tryptophan crosslink between an Fc peptide and a Fab peptide. This report is the first time either of these two crosslinks have been reported for antibodies with detailed analytical characterization. Because the behavior observed in these studies is not representative of degradation under typical storage conditions relevant to the manufacturing process, this study demonstrates that small scale stress studies in metal containers should be performed with caution and that extended incubation times can lead to non-representative degradation mechanisms.
卫生当局要求在相关的结构材料中显示药物物质的稳定性。ICH Q1A(R2)明确规定,“应在与拟用于储存和分销的包装相同或模拟包装的容器封闭系统中对药物物质进行稳定性研究”。不锈钢容器通常用于长期储存冷冻原料药(DS)。由于其耐腐蚀性更高且铁含量显着降低,因此有时会使用基于哈氏合金的金属容器来降低与高盐配方相关的潜在腐蚀风险。尽管有这些好处,但我们发现,在小型哈氏合金容器中进行高温稳定性研究可能会导致降解,而这种降解并不代表与制造过程相关的典型储存条件下的降解。我们提供了基于 Fenton 化学的氧化诱导聚集机制的证据,其中过氧化物是由聚山梨醇酯在应激温度下的自动氧化提供的。此外,还表明个体小型容器中铁浸出率的变化是降解速率变化的原因,这是通过浸出铁水平与氧化和聚集程度之间的强相关性来实现的。通过从配方中添加金属螯合剂或去除聚山梨醇酯,可以减轻氧化和非代表性行为。通过 LC-MS 和 O 标记肽图的扩展表征表明,在这些条件下形成的大部分聚集体是共价交联的,并且主要的共价物质是 Fc 肽和 Fab 肽之间的二酪氨酸或酪氨酸-色氨酸交联。本报告首次详细分析了这两种交联物在具有抗体的条件下的特征。由于在这些研究中观察到的行为不能代表与制造过程相关的典型储存条件下的降解,因此该研究表明,金属容器中的小型压力研究应谨慎进行,并且延长孵育时间可能会导致非代表性的降解机制。